Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer (R01)

This grant will support the development of state-of-the-art projects that include imaging, biomarkers, digital pathomic and other -omic integration strategies for improving current approaches for the earliest detection of premetastatic aggressive cancer as well as identifying precancerous lesions that will subsequently demonstrate an aggressive phenotype.

Funding: No fixed limit 

Durtion: 5 years

Research Autority due date: 10 days prior to submission

LOI (encouraged) due dates: 10.6.19, 10.11.19, 10.6.20, 10.11.20, 9.6.21, 10.11.21

Full proposal due dates: 10.7.19, 10.12.19, 10.7.20, 10.12.20, 9.7.21, 10.12.21